• 1
    Marinker M, Blenkinsopp A, Bond C et al. (eds) From Compliance to Concordance: Achieving Shared Goals in Medicine Taking. London: Royal Pharmaceutical Society of Great Britain, 1997.
  • 2
    Cox K, Stevenson FA, Britten N, Dundar Y. A Systematic Review of Communication Between Patients and Health care Professionals about Medicine-taking and Prescribing. London: Medicines Partnership, 2004. Available online at
  • 3
    Erickson SR, Kirking DM, Sandusky M. Michigan Medicaid recipients’ perceptions of medication counseling as required by OBRA ’90. Journal of the American Pharmaceutical Association, 1998; 38: 333338.
  • 4
    Meystre-Agustoni G. Antiretroviral therapies from the patient's perspective. AIDS Care, 2000; 12: 717721.
  • 5
    Smith DH, Cunningham KG, Hale WE. Communication about medicines: perceptions of the ambulatory elderly. Health Communication, 1994; 6: 295.
  • 6
    Morse EV, Simon PM, Coburn M, Hyslop N, Greenspan D, Balson PM. Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science and Medicine, 1991; 32: 11611167.
  • 7
    Holloway A. Patient knowledge and information concerning medication on discharge from hospital. Journal of Advanced Nursing, 1996; 24: 11691174.
  • 8
    Griffiths F. Women's decisions about whether or not to take hormone replacement therapy: influence of social and medical factors. British Journal of General Practice, 1995; 45: 477480.
  • 9
    Marshall BC, Cunny KA, Lawson KA. HIV-positive males’ satisfaction with pharmacy services. Journal of the American Pharmaceutical Association, 1997; NS37: 6675.
  • 10
    Lin EHB, Vonkorff M, Katon W et al. The role of the primary-care physician in patients adherence to antidepressant therapy. Medical Care, 1995; 33: 6774.
  • 11
    Bond M, Bywaters P. Towards understanding women's decisions to cease HRT. Journal of Advanced Nursing, 1999; 29: 852858.
  • 12
    Hargie O, Morrow N, Woodman C. Consumer perceptions of and attitudes to community pharmacy services. Pharmaceutical Journal, 1992; 249: 688691.
  • 13
    Livingstone C. Verbal interactions between elderly people and community pharmacists about prescription medicines. International Journal of Pharmaceutical Practice, 1996; 4: 1218.
  • 14
    Fahy K, Smith P. From the sick role to subject positions: a new approach to the medical encounter. Health, 1999; 3: 7193.
  • 15
    Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: qualitative study. British Medical Journal, 2000; 320: 484488.
  • 16
    Stevenson FA, Barry CA, Britten N, Barber N, Bradley CP. Doctor-patient communication about drugs: the evidence for shared decision making. Social Science and Medicine, 2000; 50: 829840.
  • 17
    Elwyn G, Gwyn R, Edwards A, Grol R. Is ‘shared decision-making’ feasible in consultations for upper respiratory tract infections? Assessing the influence of antibiotic expectations using discourse analysis. Health Expectations, 1999; 2: 105117.
  • 18
    Sleath B, Chewning B, Svarstad B, Roter D. Patient expression of complaints and adherence problems with medications during chronic disease medical visits. Journal of Social and Administrative Pharmacy, 2000; 17: 7180.
  • 19
    Kjellgren KI, Svensson S, Ahlner J, Saljo R. Antihypertensive medication in clinical encounters. International Journal of Cardiology, 1998; 64: 161169.
  • 20
    Montbriand MJ. Senior and health-professionals’ perceptions and communication about prescriptions and alternative therapies. Canadian Journal on Aging, 2000; 19: 3556.
  • 21
    Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision making? Social Science and Medicine, 1992; 34: 507513.
  • 22
    Smith F, Francis S-A, Rowley E. Group interviews with people taking long-term medication: comparing the perspectives of people with arthritis, respiratory disease and mental health problems. International Journal of Pharmaceutical Practice, 2000; 8: 8896.
  • 23
    Smith-Dupre AA, Beck CS. Enabling patients and physicians to pursue multiple goals in health care encounters: a case study. Health Communication, 1996; 8: 7390.
  • 24
    Barry CA, Bradley CP, Britten N, Stevenson FA, Barber N. Patients’ unvoiced agendas in general practice consultations: qualitative study. British Medical Journal, 2000; 320: 12461250.
  • 25
    Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patients’ expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. British Medical Journal, 1997; 315: 12111214.
  • 26
    Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners’ and patients’ perceptions of antibiotics for sore throats. British Medical Journal, 1998; 317: 637642.
  • 27
    Sleath B, Roter D, Chewning B, Svarstad B. Asking questions about medication – analysis of physician-patient interactions and physician perceptions. Medical Care, 1999; 37: 11691173.
  • 28
    Kjellgren KI, Svensson S, Ahlner J, Saljo R. Antihypertensive treatment and patient autonomy – the follow-up appointment as a resource for care. Patient Education and Counseling, 2000; 40: 3949.
  • 29
    McGrath JM. Physicians’ perspectives on communicating prescription drug information. Qualitative Health Research, 1999; 9: 731745.
  • 30
    Makoul G, Arntson P, Schofield T. Health promotion in primary-care – physician-patient communication and decision-making about prescription medications. Social Science and Medicine, 1995; 41: 12411254.
  • 31
    Francke AL, Theeuwen I. Inhibition in expressing pain. A qualitative study among Dutch surgical breast cancer patients. Cancer Nursing, 1994; 17: 193199.
  • 32
    Stevenson FA, Greenfield SM, Jones M, Nayak A, Bradley CP. GPs’ perceptions of patient influence on prescribing. Family Practice, 1999; 16: 255261.
  • 33
    Gwyn R, Elwyn G. When is a shared decision not (quite) a shared decision? Negotiating preferences in a general practice encounter. Social Science and Medicine, 1999; 49: 437447.
  • 34
    Higuchi K, Kubo T, Tsuji S, Mukai E, Tsukamoto T, Morita S. Development and assessment of the pharmaceutical management and guidance services for inpatients considering clinical value and economy. Yakugaku Zasshi. Journal of the Pharmaceutical Society of Japan, 1999; 119: 710730.
  • 35
    Pilnick A. ‘Why didn't you say just that?’ Dealing with issues of asymmetry, knowledge and competence in the pharmacist/client encounter. Sociology of Health and Illness, 1998; 20: 2951.
  • 36
    Dayan-Lintzer M, Klein P. Galenic, concerted choice and compliance in hormonal replacement therapy [French]. Contraception, Fertilite, Sexualite, 1999; 27: 318321.
  • 37
    Schneider HPG. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe. International Journal of Fertility and Women, 1997; 42: 365375.
  • 38
    Makoul G. Perpetuating passivity: reliance and reciprocal determinism in physician-patient interaction. Journal of Health Communication, 1998; 3: 233259.
  • 39
    Parrott R. Exploring family practitioners’ and patients’ information exchange about prescribed medications: implications for practitioners’ interviewing and patients’ understanding. Health Communication, 1994; 6: 280.
  • 40
    Hassell K, Noyce P, Rogers A, Harris J, Wilkinson J. Advice provided in British community pharmacies: what people want and what they get. Journal of Health Services and Research Policy, 1998; 3: 219225.
  • 41
    Taylor J. Reasons consumers do not ask for advice on non-prescription medicines in pharmacies. International Journal of Pharmaceutical Practice, 1994; 2: 209214.
  • 42
    Freeman GK, Richards SC. Personal continuity and the care of patients with epilepsy in general practice. British Journal of General Practice, 1994; 44: 395399.
  • 43
    Bultman DC, Svarstad BL. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Education and Counseling, 2000; 40: 173185.
  • 44
    Siminoff LA, Ravdin P, Colabianchi N, Sturm CMS. Doctor-patient communication patterns in breast cancer adjuvant therapy discussions. Health Expectations, 2000; 3: 2636.
  • 45
    Dow MG, Verdi MB, Sacco WP. Training psychiatric patients to discuss medication issues. Effects on patient communication and knowledge of medications. Behavior Modification, 1991; 15: 321.
  • 46
    Evans M, Macpherson R, Thompson E, Babiker I. Educating psychiatric patients about their treatment: do fact sheets work? Journal of the Royal Society of Medicine, 1996; 89: 690693.
  • 47
    Aufseesser-Stein M, Ruttimann S, Lacroix A, Assal JP. Swiss educational experience with a prescription dialogue in ambulatory medicine [French]. Schweizerische Rundschau fur Medizin Praxis, 1992; 81: 142146.
  • 48
    Clark NM, Gong M, Schork A et al. Impact of education for physicians on patient outcomes. Pediatrics, 1998; 101: 831836.
  • 49
    Lacroix A, Courvoisier F, Aufseesser-Stein M, Assal JP. The dialogue of prescribing. Gaps and possibilities for improvement with a brief interactive seminar [French]. Schweizerische Rundschau fur Medizin Praxis, 1992; 81: 138141.
  • 50
    Clark NM, Gong M, Schork MA et al. Long-term effects of asthma education for physicians on patient satisfaction and use of health services. European Respiratory Journal, 2000; 16: 1521.
  • 51
    Airaksinen M, Ahonen R, Enlund H. The ‘Questions to Ask About Your Medicines’ campaign – an evaluation of pharmacists and the public's response. Medical Care, 1998; 36: 422427.
  • 52
    Barnett CW, Nykamp D, Ellington AM. Patient-guided counseling in the community pharmacy setting. Journal of the American Pharmaceutical Association (Washington), 2000; 40: 765772.
  • 53
    Kradjan WA, Schulz R, Christensen DB, Stergachis A, Sullivan S, Fullerton DS et al. Patients’ perceived benefit from and satisfaction with asthma-related pharmacy services. Journal of the American Pharmaceutical Association (Washington), 1999; 39: 658666.
  • 54
    Gourley GA, Portner TS, Gourley DR et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. Journal of the American Pharmaceutical Association, 1998; 38: 586597.
  • 55
    Blenkinsopp A, Phelan M, Bourne J, Dakhil N. Extended adherence support by community pharmacists for patients with hypertension: a randomised controlled trial. International Journal of Pharmacy Practice, 2000; 8: 3175.
  • 56
    Raynor DK, Nicolson MNJ, Petty D, Vail ADL. The development and evaluation of an extended adherence support programme by community pharmacists for elderly patients at home. The International Journal of Pharmacy Practice, 2000; 8: 157164.
  • 57
    Soloman DK, Portner TS, Bass GE et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. Journal of the American Pharmaceutical Association, 1998; 38: 574585.
  • 58
    Schectman G, Hiatt J, Hartz A. Telephone contacts do not improve adherence to niacin or bile acid sequestrant therapy. Annals of Pharmacotherapy, 1994; 28: 2935.
  • 59
    Kelly DF, Faught WJ, Holmes LA. Ovarian cancer treatment: the benefit of patient telephone follow-up post-chemotherapy. Canadian Oncology Nursing Journal, 1999; 9: 175178.
  • 60
    Mills N, Bachmann MO, Harvey I, Hine I, McGowan M. Effect of a primary-care-based epilepsy specialist nurse service on quality of care from the patients’ perspective: quasi-experimental evaluation. Seizure, 1999; 8: 17.
  • 61
    Hanna KM. Effect of nurse-client transaction on female adolescents’ oral contraceptive adherence. Image – the Journal of Nursing Scholarship, 1993; 25: 285290.
  • 62
    Wildersmith CH, Schuler L. Postoperative analgesia - pain by choice - the influence of patient attitudes and patient education. Pain, 1992; 50: 257262.